Impact of comorbidity on the outcome in men with advanced prostate cancer treated with docetaxel

URN:NBN:SI:doc-IQAZK6VA2015Amir, EitanOcana, AlbertoŠeruga, BoštjanŽist, Andrejdocuments/doc/I/URN_NBN_SI_doc-IQAZK6VA_001.pdfdocuments/doc/I/URN_NBN_SI_doc-IQAZK6VA_001.txt449articlestr. 402-408, VII1318-20992215291URN:NBN:SI:doc-IQAZK6VAengAssociation of Radiology and OncologyRadiology and oncology (Ljubljana)BYchemotherapycomorbiditykemoterapijametastatic castration-resistant prostate cancerpridružene bolezniprostataprostateprostate cancerrak (medicina)Impact of comorbidity on the outcome in men with advanced prostate cancer treated with docetaxel